Methyl 5-bromo-3-cyclopropyl-1,2-oxazole-4-carboxylate

Catalog No.: 
ACBRYI321
CAS No.: 
2092373-87-8
Molecular Formula: 
C8H8BrNO3
Molecular Weight: 
246.06
Methyl 5-bromo-3-cyclopropyl-1,2-oxazole-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$228.00InquiryInquiry
100mg95%$332.00InquiryInquiry
250mg95%$469.00InquiryInquiry
1g95%$928.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-bromo-3-cyclopropyl-1,2-oxazole-4-carboxylate
IUPAC Namemethyl 5-bromo-3-cyclopropylisoxazole-4-carboxylate
Molecular FormulaC8H8BrNO3
Molecular Weight246.06
SMILESO=C(C1=C(Br)ON=C1C2CC2)OC
InChI KeyAMBQACYDIKMNTK-UHFFFAOYSA-N
Synonym4-Isoxazolecarboxylic acid, 5-bromo-3-cyclopropyl-, methyl ester;Methyl 5-bromo-3-cyclopropylisoxazole-4-carboxylate;Methyl 5-bromo-3-cyclopropyl-1,2-oxazole-4-carboxylate
CAS No.2092373-87-8

Synthetic Route by SureRoute

1. ACBRYI321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBRYI321 route product structure diagram
    ACBRYI3212092373-87-8
Inquiry

2. ACBRYI321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7In Stock
  4. Then
  5. ACBRYI321 route product structure diagram
    ACBRYI3212092373-87-8
Inquiry

3. ACBRYI321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWDA697 route compound structure diagram
    ACCWDA69713061-96-6
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBRYI321 route product structure diagram
    ACBRYI3212092373-87-8
Inquiry

Comments (0)